How severe is CVE-2024-2277?

CVE-2024-2277 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-2277 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-2277?

CVE-2024-2277 affects Bdtask G-prescription Gynaecology & Obs Consultation. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-2277?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-2277 have an EU (EUVD) identifier?

Yes. CVE-2024-2277 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-27232.

When was CVE-2024-2277 published?

CVE-2024-2277 was published on 2024-03-08 and last updated on 2026-06-17.

CVE-2024-2277

CVE-2024-2277 is a medium-severity vulnerability in Bdtask G-prescription Gynaecology & Obs Consultation with a CVSS 3.x base score of 4.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-352.

Key facts

Severity: Medium (CVSS 3.x base score 4.3)
CVSS v2: 5.0
EPSS exploit prediction: 0% (25th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-27232
Weakness: CWE-352
Affected product: Bdtask G-prescription Gynaecology & Obs Consultation
Published: 2024-03-08
Last modified: 2026-06-17

Description

A vulnerability was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this issue is some unknown functionality of the file /Setting/change_password_save of the component Password Reset Handler. The manipulation leads to cross-site request forgery. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. VDB-256046 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Frequently asked questions

What is CVE-2024-2277?: A vulnerability was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this issue is some unknown functionality of the file /Setting/change_password_save of the component Password Reset Handler. The manipulation leads to cross-site request forgery. The attack may be launched remotely. The exploit has been disclosed to the public and may be used. VDB-256046 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
How severe is CVE-2024-2277?: CVE-2024-2277 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-2277 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (25th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-2277?: CVE-2024-2277 affects Bdtask G-prescription Gynaecology & Obs Consultation. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-2277?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-2277 have an EU (EUVD) identifier?: Yes. CVE-2024-2277 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-27232.
When was CVE-2024-2277 published?: CVE-2024-2277 was published on 2024-03-08 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:bdtask:g-prescription_gynaecology_\&_obs_consultation:1.0:*:*:*:*:*:*:*

More vulnerabilities in Bdtask G-prescription Gynaecology & Obs Consultation

CVE-2024-2276 — Low (CVSS 2.4): A vulnerability has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as…
CVE-2024-2275 — Low (CVSS 2.4): A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation…
CVE-2024-2274 — Low (CVSS 2.4): A vulnerability, which was classified as problematic, has been found in Bdtask G-Prescription Gynaecology & OBS…

All CVEs affecting Bdtask G-prescription Gynaecology & Obs Consultation →

Other CWE-352 (Cross-Site Request Forgery (CSRF)) vulnerabilities

CVE-2025-32642 — Critical (CVSS 10.0): Cross-Site Request Forgery (CSRF) vulnerability in appsbd Vite Coupon vite-coupon allows Remote Code Inclusion.This…
CVE-2025-23922 — Critical (CVSS 10.0): Cross-Site Request Forgery (CSRF) vulnerability in Harsh iSpring Embedder embed-ispring allows Upload a Web Shell to a…
CVE-2017-5145 — Critical (CVSS 10.0): An issue was discovered in Carlo Gavazzi VMU-C EM prior to firmware Version A11_U05, and VMU-C PV prior to firmware…
CVE-2019-25729 — Critical (CVSS 9.8): PDF Signer 3.0 contains a server-side template injection vulnerability that allows unauthenticated attackers to execute…
CVE-2025-48340 — Critical (CVSS 9.8): Cross-Site Request Forgery (CSRF) vulnerability in Danny Vink User Profile Meta Manager user-profile-meta allows…
CVE-2025-2907 — Critical (CVSS 9.8): The Order Delivery Date WordPress plugin before 12.3.1 does not have authorization and CSRF checks when importing…

Browse all CWE-352 (Cross-Site Request Forgery (CSRF)) vulnerabilities →